Michael J. Robinson

3.1k total citations
66 papers, 2.3k citations indexed

About

Michael J. Robinson is a scholar working on Pharmacology, Psychiatry and Mental health and Physiology. According to data from OpenAlex, Michael J. Robinson has authored 66 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmacology, 15 papers in Psychiatry and Mental health and 14 papers in Physiology. Recurrent topics in Michael J. Robinson's work include Treatment of Major Depression (12 papers), Neonatal Respiratory Health Research (8 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (7 papers). Michael J. Robinson is often cited by papers focused on Treatment of Major Depression (12 papers), Neonatal Respiratory Health Research (8 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (7 papers). Michael J. Robinson collaborates with scholars based in United States, United Kingdom and Canada. Michael J. Robinson's co-authors include James McCulloch, I. Mhairi Macrae, John L. Reid, Yili Pritchett, Amy S. Chappell, Apurva Prakash, James M. Martinez, John T. Farrar, Paul T. Heath and David I. Graham and has published in prestigious journals such as Diabetes Care, PEDIATRICS and Cancer Research.

In The Last Decade

Michael J. Robinson

66 papers receiving 2.2k citations

Peers

Michael J. Robinson
Monique van Velzen Netherlands
Susan Ball United States
Pamela Flood United States
Paul J. Christo United States
Gary L. Pierce United States
David B. Clifford United States
Suzi Hong United States
Adam D. Farmer United Kingdom
Monique van Velzen Netherlands
Michael J. Robinson
Citations per year, relative to Michael J. Robinson Michael J. Robinson (= 1×) peers Monique van Velzen

Countries citing papers authored by Michael J. Robinson

Since Specialization
Citations

This map shows the geographic impact of Michael J. Robinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Robinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Robinson more than expected).

Fields of papers citing papers by Michael J. Robinson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Robinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Robinson. The network helps show where Michael J. Robinson may publish in the future.

Co-authorship network of co-authors of Michael J. Robinson

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Robinson. A scholar is included among the top collaborators of Michael J. Robinson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Robinson. Michael J. Robinson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Robinson, Michael J. & Elizabeth J. Davis. (2024). Neoadjuvant Chemotherapy for Adults with Osteogenic Sarcoma. Current Treatment Options in Oncology. 25(11). 1366–1373. 5 indexed citations
2.
Robinson, Michael J., et al.. (2024). AAV gene replacement therapy for treating MPS IIIC: Facilitating bystander effects via EV‐mRNA cargo. Journal of Extracellular Vesicles. 13(7). e12464–e12464. 2 indexed citations
3.
Robinson, Michael J., David V. Sheehan, Paula J. Gaynor, et al.. (2013). Relationship between major depressive disorder and associated painful physical symptoms. International Clinical Psychopharmacology. 28(6). 330–338. 11 indexed citations
4.
Robinson, Michael J., et al.. (2013). Aspiration under anaesthesia: risk assessment and decision-making. Continuing Education in Anaesthesia Critical Care & Pain. 14(4). 171–175. 70 indexed citations
5.
Gaynor, Paula J., Wei Zheng, James M. Martinez, et al.. (2011). Duloxetine versus placebo in the treatment of major depressive disorder and associated painful physical symptoms: a replication study. Current Medical Research and Opinion. 27(10). 1859–1867. 27 indexed citations
7.
Bradley, Laurence A., Madelaine M. Wohlreich, Fujun Wang, et al.. (2010). Pain Response Profile of Patients With Fibromyalgia Treated With Duloxetine. Clinical Journal of Pain. 26(6). 498–504. 10 indexed citations
8.
Goddard, Andrew W., Susan Ball, James M. Martinez, et al.. (2009). Current perspectives of the roles of the central norepinephrine system in anxiety and depression. Depression and Anxiety. 27(4). 339–350. 238 indexed citations
9.
Farrar, John T., Yili Pritchett, Michael J. Robinson, Apurva Prakash, & Amy S. Chappell. (2009). The Clinical Importance of Changes in the 0 to 10 Numeric Rating Scale for Worst, Least, and Average Pain Intensity: Analyses of Data from Clinical Trials of Duloxetine in Pain Disorders. Journal of Pain. 11(2). 109–118. 205 indexed citations
10.
Wasan, Ajay D., Joel Raskin, Joachim Wernicke, et al.. (2009). Safety and Efficacy of Duloxetine in the Treatment of Diabetic Peripheral Neuropathic Pain in Older Patients. Current Drug Safety. 4(1). 22–29. 25 indexed citations
11.
Wise, Thomas N., et al.. (2008). The Significance of Treating Somatic Symptoms on Functional Outcome Improvement in Patients With Major Depressive Disorder. The Primary Care Companion to The Journal of Clinical Psychiatry. 10(4). 270–275. 21 indexed citations
12.
Ganesh, Shanthi, Neeraja Idamakanti, Melinda VanRoey, et al.. (2007). Relaxin-Expressing, Fiber Chimeric Oncolytic Adenovirus Prolongs Survival of Tumor-Bearing Mice. Cancer Research. 67(9). 4399–4407. 83 indexed citations
13.
Alibhai, Shabbir M.H., Michael J. Robinson, George Tomlinson, et al.. (2007). Recognition and labeling of delirium symptoms by intensivists: Does it matter?. Intensive Care Medicine. 34(3). 437–446. 26 indexed citations
14.
Clarke, Paul, et al.. (2006). Nasal continuous positive airway pressure for neonatal back transfer. Acta Paediatrica. 95(6). 752–753. 4 indexed citations
15.
Rüggeberg, J., Clare L. Collins, Paul Clarke, et al.. (2006). Immunogenicity and induction of immunological memory of the heptavalent pneumococcal conjugate vaccine in preterm UK infants. Vaccine. 25(2). 264–271. 43 indexed citations
16.
Robinson, Michael J. & Roula Qaqish. (2002). Practical psychopharmacology in HIV-1 and acquired immunodeficiency syndrome. Psychiatric Clinics of North America. 25(1). 149–175. 10 indexed citations
17.
Robinson, Michael J. & James L. Levenson. (2000). The use of psychotropics in the medically ill. Current Psychiatry Reports. 2(3). 247–255. 4 indexed citations
18.
Dawson, Deborah A., et al.. (1992). Autoradiographic evaluation of forskolin and D1 dopamine receptor binding in a rat model of focal cerebral ischaemia. Brain Research. 577(2). 210–217. 12 indexed citations
19.
Robinson, Michael J., I. Mhairi Macrae, Mary E. Todd, James Reid, & James McCulloch. (1991). Reduction in Local Cerebral Blood Flow Induced by Endothelin-1 Applied Topically to the Middle Cerebral Artery in the Rat. Journal of Cardiovascular Pharmacology. 17. S354–357. 18 indexed citations
20.
Mawer, E.B., et al.. (1986). VITAMIN D NUTRITION AND VITAMIN D METABOLISM IN THE PREMATURE HUMAN NEONATE. Clinical Endocrinology. 25(6). 641–649. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026